Bayesian sequential monitoring strategies for trials of digestive cancer therapeutics
Abstract Background New therapeutics in oncology have presented challenges to existing paradigms and trial designs in all phases of drug development. As a motivating example, we considered an ongoing phase II trial planned to evaluate the combination of a MET inhibitor and an anti-PD-L1 immunotherap...
Saved in:
| Main Authors: | Guillaume Mulier, Ruitao Lin, Thomas Aparicio, Lucie Biard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-07-01
|
| Series: | BMC Medical Research Methodology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12874-024-02278-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2
by: Nina Deliu, et al.
Published: (2024-10-01) -
The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trial
by: Charlotte Gaskell, et al.
Published: (2025-05-01) -
Bayesian dynamic borrowing in group-sequential design for medical device studies
by: Maria Vittoria Chiaruttini, et al.
Published: (2025-03-01) -
Navigating challenges in pediatric trial conduct: integrating bayesian sequential design with semiparametric elicitation for handling primary and secondary endpoints
by: Danila Azzolina, et al.
Published: (2025-03-01) -
Adaptive EMG Pattern Classification via Probabilistic Knowledge Transfer With Scale Mixture-Based Bayesian Sequential Learning
by: Seitaro Yoneda, et al.
Published: (2025-01-01)